The prevalence of Chronic Obstructive Pulmonary Disorder (COPD) is closely correlated with exposure to the smoking of tobacco. The World Health Organization (WHO) estimates that tobacco use will account for 90% of all instances of chronic obstructive pulmonary disease (COPD) by the year 2021. Because to the permanent harm caused by smoking, people are forced to change their lifestyles and seek medical treatment, which increases demand for Pulmonary Drugs Market by encouraging the use of bronchodilators, inhaled glucocorticoids, inhaled steroids, and other pulmonary therapies to address disease symptoms. Over the world, tobacco smoking is a leading cause of sickness and death.
The number of smokers remains stable over the world and has not decreased in recent years.
Read More:
https://knackersblogger.blogspot.com/2023/03/pulmonary-drugs-market-size-share.html
Facebook Conversations